WEREWOLF THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
WEREWOLF THERAPEUTICS, INC. (HOWL) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 8.21 million shares as of 2026-06-30, per its S-4 filed 2026-09-22.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-09-22
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8.21M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8.44M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 9.95M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 9.95M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number |
|---|---|
| 2026-06-30 | 8.21M shares S-4 · filed 2026-09-22 |
| 2026-03-31 | 8.44M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 9.95M shares 10-Q · filed 2026-07-31 |
| 2024-12-31 | 9.95M shares S-4 · filed 2026-09-22 |
| 2023-03-31 | 6.67M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 5.24M shares 10-Q · filed 2023-05-11 |
| 2022-09-30 | 5.28M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 4.38M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 4.13M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 3.27M shares 10-Q · filed 2022-11-10 |
| 2021-09-30 | 3.28M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 2.88M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 2.40M shares 10-Q · filed 2021-06-10 |
| 2020-12-31 | 2.06M shares 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |